Isosorbide Dinitrate

Isosorbide Dinitrate

SCHEMBL3008938

O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-].[Na+]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GUCY1A1GUCY1A2GUCY1B1GUCY1B2

The experimentally established mechanism targets of Isosorbide Dinitrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.95
MAPT P10636 1/20 0.75
BCHE P06276 6/20 0.62
GSR P00390 8/20 0.45
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isosorbide Dinitrate SCHEMBL27976716 0.98 ALDH1A1 (0.91) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL9439417 0.98 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL29532755 0.98 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL19528695 0.98 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL8253 0.98 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL309369 0.98 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL1553054 0.98 ALDH1A1 (1.00) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL714959 0.95 ALDH1A1 (0.95) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL28209664 0.93 ALDH1A1 (0.91) ALDH1A1MAPTBCHEGSRCA2
Isosorbide Dinitrate SCHEMBL3864281 0.91 ALDH1A1 (0.88) ALDH1A1MAPTBCHEGSRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431609-B2 Process for preparation of pyrazole derivatives SHAH DARMESH MAHENDRABHAI (IN) 2013-04-30 US claimed
US-20100190988-A1 PROCESS FOR PREPARATION OF PYRAZOLE DERIVATIVES SHAH DARMESH MAHENDRABHAI 2010-07-29 US claimed
US-7696299-B2 Fast crystallizing modified polyethylene naphthalate FUTURA POLYESTERS LIMITED (IN) 2010-04-13 US claimed
WO-2008102367-A1 PROCESS FOR PREPARATION OF PYRAZOLE DERIVATIVES SHAH DARMESH MAHENDRABHAI (IN) 2008-08-28 WO claimed
US-20070203324-A1 Fast crystallizing modified polyethylene naphthalate FUTURA POLYESTERS LIMITED (IN) 2007-08-30 US claimed
US-8431609-B2 Process for preparation of pyrazole derivatives SHAH DARMESH MAHENDRABHAI (IN) 2013-04-30 US disclosed
US-20100190988-A1 PROCESS FOR PREPARATION OF PYRAZOLE DERIVATIVES SHAH DARMESH MAHENDRABHAI 2010-07-29 US disclosed
US-7696299-B2 Fast crystallizing modified polyethylene naphthalate FUTURA POLYESTERS LIMITED (IN) 2010-04-13 US disclosed
WO-2008102367-A1 PROCESS FOR PREPARATION OF PYRAZOLE DERIVATIVES SHAH DARMESH MAHENDRABHAI (IN) 2008-08-28 WO disclosed
US-20070203324-A1 Fast crystallizing modified polyethylene naphthalate FUTURA POLYESTERS LIMITED (IN) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190988-A1 PROCESS FOR PREPARATION OF PYRAZOLE DERIVATIVES PDXK, PYCR1, PPOX ALDH1A1 4459/4885MAPT 3662/4885BCHE 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.